Northern Trust Corp Myriad Genetics Inc Transaction History

Northern Trust Corp

  • $572 Billion
  • Q1 2024

A detailed history of Northern Trust Corp transactions in Myriad Genetics Inc stock. As of the latest transaction made, Northern Trust Corp holds 956,356 shares of MYGN stock, worth $23.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
956,356
Previous 942,137 1.51%
Holding current value
$23.4 Million
Previous $18 Million 13.07%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$17.59 - $23.59 $250,112 - $335,426
14,219 Added 1.51%
956,356 $20.4 Million
Q4 2023

Feb 13, 2024
SELL
$13.91 - $21.32 $1.11 Million - $1.71 Million
-80,002 Reduced 7.83%
942,137 $18 Million
Q3 2023

Nov 13, 2023
BUY
$15.99 - $23.22 $35,785 - $51,966
2,238 Added 0.22%
1,022,139 $16.4 Million
Q2 2023

Aug 11, 2023
BUY
$17.56 - $23.76 $398,717 - $539,494
22,706 Added 2.28%
1,019,901 $23.6 Million
Q1 2023

May 15, 2023
SELL
$15.26 - $23.75 $185,576 - $288,823
-12,161 Reduced 1.2%
997,195 $23.2 Million
Q4 2022

Feb 13, 2023
SELL
$14.51 - $20.99 $2.82 Million - $4.08 Million
-194,425 Reduced 16.15%
1,009,356 $14.6 Million
Q3 2022

Nov 14, 2022
SELL
$18.21 - $27.88 $591,169 - $905,096
-32,464 Reduced 2.63%
1,203,781 $23 Million
Q2 2022

Aug 12, 2022
SELL
$16.45 - $25.88 $122,026 - $191,977
-7,418 Reduced 0.6%
1,236,245 $22.5 Million
Q1 2022

May 13, 2022
SELL
$22.67 - $28.01 $933,074 - $1.15 Million
-41,159 Reduced 3.2%
1,243,663 $31.3 Million
Q4 2021

Feb 08, 2022
SELL
$24.13 - $32.63 $24,636 - $33,315
-1,021 Reduced 0.08%
1,284,822 $35.5 Million
Q3 2021

Nov 15, 2021
SELL
$29.97 - $36.66 $976,482 - $1.19 Million
-32,582 Reduced 2.47%
1,285,843 $41.5 Million
Q2 2021

Aug 13, 2021
BUY
$25.39 - $32.61 $1.39 Million - $1.79 Million
54,934 Added 4.35%
1,318,425 $40.3 Million
Q1 2021

May 12, 2021
SELL
$19.92 - $31.6 $8.94 Million - $14.2 Million
-448,625 Reduced 26.2%
1,263,491 $38.5 Million
Q4 2020

Feb 11, 2021
SELL
$12.16 - $19.77 $1.81 Million - $2.94 Million
-148,739 Reduced 7.99%
1,712,116 $33.9 Million
Q3 2020

Nov 16, 2020
SELL
$11.25 - $14.75 $703,451 - $922,302
-62,529 Reduced 3.25%
1,860,855 $24.3 Million
Q2 2020

Aug 14, 2020
BUY
$10.69 - $16.49 $356,490 - $549,908
33,348 Added 1.76%
1,923,384 $21.8 Million
Q1 2020

May 14, 2020
BUY
$9.78 - $29.53 $87,081 - $262,935
8,904 Added 0.47%
1,890,036 $27 Million
Q4 2019

Feb 14, 2020
SELL
$20.93 - $35.1 $328,245 - $550,473
-15,683 Reduced 0.83%
1,881,132 $51.2 Million
Q3 2019

Nov 13, 2019
BUY
$22.08 - $47.08 $2.24 Million - $4.77 Million
101,347 Added 5.64%
1,896,815 $54.3 Million
Q2 2019

Aug 13, 2019
BUY
$22.67 - $35.0 $2.35 Million - $3.63 Million
103,590 Added 6.12%
1,795,468 $49.9 Million
Q1 2019

May 13, 2019
SELL
$26.93 - $34.7 $5,412 - $6,974
-201 Reduced 0.01%
1,691,878 $56.2 Million
Q4 2018

Feb 12, 2019
BUY
$27.23 - $45.56 $927,617 - $1.55 Million
34,066 Added 2.05%
1,692,079 $49.2 Million
Q3 2018

Nov 14, 2018
SELL
$37.57 - $50.34 $5.41 Million - $7.24 Million
-143,869 Reduced 7.98%
1,658,013 $76.3 Million
Q2 2018

Sep 18, 2018
SELL
$27.75 - $40.17 $126,179 - $182,652
-4,547 Reduced 0.25%
1,801,882 $67.3 Million
Q2 2018

Aug 14, 2018
BUY
$27.75 - $40.17 $1.46 Million - $2.11 Million
52,541 Added 3.0%
1,806,429 $67.5 Million
Q1 2018

May 09, 2018
BUY
$28.83 - $41.01 $2.97 Million - $4.22 Million
102,920 Added 6.23%
1,753,888 $51.8 Million
Q4 2017

Feb 14, 2018
BUY
$28.45 - $37.14 $3.36 Million - $4.38 Million
117,934 Added 7.69%
1,650,968 $56.7 Million
Q3 2017

Nov 13, 2017
BUY
$24.01 - $36.2 $36.8 Million - $55.5 Million
1,533,034
1,533,034 $55.5 Million

Others Institutions Holding MYGN

# of Institutions
191
Shares Held
94.2M
Call Options Held
280K
Put Options Held
14.3K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.97B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email